Enhancing the Capacity and Capability of Human Food and Environmental Testing Laboratory at the Texas Department of State Health Services: Radiochemistry Food Defense

项目摘要 C学科放射化学，第一轨道食品防御 根据这项合作协议，德克萨斯州卫生部的主要目标是 实验室服务科(DHS)放射化学组将确保人类 在德克萨斯州制造和/或分销的食品和人类食品是安全的，确定 是否存在放射性污染，并确定放射性核素的身份 存在于人体样本中。数据将被用来描述食品污染的程度， 发现趋势，计算收入。DHS LSS计划参与以下活动 实现这些目标的具体目标和活动。 1.对数据进行分类，以确定是否需要进一步分析； 2.利用结果来确定污染是远高于还是远低于监管限值； 3.参加FDA要求的分类工作，和/或监督活动，以支持和 保持准备状态。 4.如有可能，参加国家安全事件演习。 5.参加并通过本项目所开展工作的年度水平测试(PT)。 6.通过参加预定的电话会议、会议和蕨类活动来保持蕨类的会员资格 活动。 7.放射化学集团的两名工作人员将参加LFFM年度面对面会议。 维护与本项目相关的测试所需的设施和人员。 9.使用FDA标准化验证方法，紧急情况除外。 10.提供通过以下途径收集和分析的所有样本的详细季度摘要 蕨类网站，这是蕨类参与者的正常程序。 11.遵循最佳实践建议，以获得适当的采样和实验室数据 记录并使用FDA Form 431或同等标准对样品进行分析。 12.在一个工作日内通知FDA项目经理和技术负责人 假定呈阳性或“不能排除”(CRO)样本并提交完整的实验室 在期末考试后三个工作日内，对任何确认阳性或违规的样品进行包装。 13.与FDA保持有效的20.88协议，并至少参与FDA要求的一次 年度任务，如果可能的话。 1

Project Summary Discipline C Radiochemistry, Track 1 Food Defense Under this cooperative agreement, the primary goals for the Texas Department of State Health Services (DSHS), Laboratory Service Section (LSS) Radiochemistry Group are to ensure human food and human food products made and/or distributed in Texas are safe, determine the presence or absence of radioactive contamination, and determine the identities of radionuclides present in human samples. Data will be used to characterize the extent of food contamination, spotting trends, and calculating intakes. The DSHS LSS plans participation in the following specific aims and activities to achieve these goals. 1. Triage data to determine whether further analysis is needed; 2. Utilize results to determine if contamination is well above or well below regulatory limits; 3. Participate in FDA-requested triage exercises, and/or surveillance activities to support and maintain readiness. 4. Participate in national security event exercises, as available. 5. Participate in and pass annual proficiency test (PT) for work performed under this project. 6. Maintain FERN membership by participating in scheduled calls, meetings, and FERN activities. 7. Two Radiochemistry Group staff will attend the annual LFFM Face-to-Face meeting. 8. Maintain facilities and personnel necessary for testing related to this project. 9. Use FDA standardized validated methods, with the exception of emergency situations. 10. Provide a detailed quarterly summary of all samples collected and analyzed through the FERN website, as is normal procedure for FERN participants. 11. Follow best practices recommendations for proper sampling and laboratory data documentation and use FDA Form 431, or equivalent, for analytical for samples. 12. Notify the FDA project manager and the technical lead within one business day of any presumptive positive or “cannot rule out” (CRO) samples and submit the full laboratory package for any confirmed positive or violative sample within three business days of final. 13. Maintain a valid 20.88 agreement with FDA and participate in at least one FDA-requested annual assignment, if possible. 1